Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer

  Free Subscription


08.09.2025

1 Adv Sci (Weinh)
1 Am J Reprod Immunol
1 Ann Med Surg (Lond)
1 Appl Immunohistochem Mol Morphol
1 Biochim Biophys Acta Mol Basis Dis
1 Biochim Biophys Acta Mol Cell Res
1 BMC Cancer
1 BMC Med Inform Decis Mak
1 BMC Public Health
1 BMJ Glob Health
1 BMJ Open
1 Br J Cancer
2 Brachytherapy
1 Braz J Med Biol Res
1 Bull World Health Organ
1 Cad Saude Publica
1 Cancer Causes Control
1 Cancer Control
1 Cancer Epidemiol Biomarkers Prev
1 Cancer Med
1 Cancer Treat Res Commun
2 Clin Oncol (R Coll Radiol)
1 Comput Biol Med
3 Cureus
1 Discov Oncol
1 Epidemiol Health
1 Folia Med Cracov
1 Front Immunol
1 Front Oncol
1 Ginekol Pol
1 Indian J Public Health
1 Int J Biol Macromol
6 Int J Gynaecol Obstet
3 Int J Gynecol Cancer
1 Int J Public Health
1 Integr Cancer Ther
1 Iran J Basic Med Sci
1 J Cancer Res Clin Oncol
1 J Cancer Res Ther
1 J Gynecol Oncol
1 J Infect Public Health
1 J Med Life
1 J Multidiscip Healthc
1 J Proteome Res
1 JNCI Cancer Spectr
1 Kaohsiung J Med Sci
1 MethodsX
1 Pathol Res Pract
2 PLoS One
1 Radiother Oncol
1 Reprod Sci
1 Rev Panam Salud Publica
1 Rev Peru Med Exp Salud Publica
1 Saudi Med J
3 Sci Rep
1 Support Care Cancer
1 Toxicol Appl Pharmacol
1 Transl Oncol
2 Turk J Obstet Gynecol
1 Women Health


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Adv Sci (Weinh)

  1. REN T, Qiu J, Chen F, Jiang Q, et al
    Targeting Glutamine Metabolism Transporter SLC25A22 Enhances CD8+ T-Cell Function and Anti-PD-1 Therapy Efficacy in Cervical Squamous Cell Carcinoma: Integrated Metabolomics, Transcriptomics and T-Cell-Incorporated Tumor Organoid Studies.
    Adv Sci (Weinh). 2025;12:e02225.
    PubMed         Abstract available


    Am J Reprod Immunol

  2. MACINAS DV JR, Tantengco OAG, de Paz-Silava SLM, Kammala AK, et al
    Comparative Analysis of Vaginal Inflammatory Cytokines Among HPV-Positive and HPV-Negative Women in Manila, Philippines.
    Am J Reprod Immunol. 2025;94:e70148.
    PubMed         Abstract available


    Ann Med Surg (Lond)

  3. OBEAGU EI
    Anemia and hematocrit decline in cervical cancer: unveiling clinical consequences and management strategies.
    Ann Med Surg (Lond). 2025;87:5784-5791.
    PubMed         Abstract available


    Appl Immunohistochem Mol Morphol

  4. KAWAGUCHI R, Uchiyama T, Sugimoto S, Kamibayashi J, et al
    Tissue Factor Pathway Inhibitor-2 Expression in Uterine Cervical Clear Cell Carcinoma: A Potential Biomarker for Clinical Diagnosis.
    Appl Immunohistochem Mol Morphol. 2025;33:315-320.
    PubMed         Abstract available


    Biochim Biophys Acta Mol Basis Dis

  5. SHEN J, Zhang D, Zheng Q, Zhang Z, et al
    ClC-3 inhibition induces autophagy to reverse cisplatin resistance in cervical cancer via the Akt/mTOR pathway.
    Biochim Biophys Acta Mol Basis Dis. 2025 Sep 2:168030.
    PubMed         Abstract available


    Biochim Biophys Acta Mol Cell Res

  6. HSIN MC, Wang PH, Chen PN, Hsieh YH, et al
    S100A16 knockdown reduces RPN2 expression and inhibits beta-catenin/TCF signaling, leading to suppressed metastasis in cervical cancer cells.
    Biochim Biophys Acta Mol Cell Res. 2025;1872:120053.
    PubMed         Abstract available


    BMC Cancer

  7. YANG Q, Han X
    Prognostic value of risk factors in cervical squamous cell carcinoma based on tumour infiltration depth.
    BMC Cancer. 2025;25:1412.
    PubMed         Abstract available


    BMC Med Inform Decis Mak

  8. JEMANE KC, Kuyu MB, Tegenaw GS
    Developing multimodal cervical cancer risk assessment and prediction model based on LMIC hospital patient card sheets and histopathological images.
    BMC Med Inform Decis Mak. 2025;25:322.
    PubMed         Abstract available


    BMC Public Health

  9. EMAGNENEH T, Mulugeta C, Ejigu B, Alamrew A, et al
    Uptake of cervical cancer screening and its associated factors in Africa: an umbrella review of systematic reviews and meta-analyses.
    BMC Public Health. 2025;25:2968.
    PubMed         Abstract available


    BMJ Glob Health

  10. NISHA M, Bateson D, Saville M, Nightingale CE, et al
    The role of non-medical providers in increasing access to cervical screening: a scoping review.
    BMJ Glob Health. 2025;10:e019041.
    PubMed         Abstract available


    BMJ Open

  11. ORANRATANAPHAN S, Moonchai K, Pohthipornthawat N, Santibenchakul S, et al
    Knowledge, attitudes and practices regarding cervical cancer screening among women in the Dindaeng community, Bangkok, Thailand: a cross-sectional community-based study.
    BMJ Open. 2025;15:e100896.
    PubMed         Abstract available


    Br J Cancer

  12. MATHEWS CS, Sargent A, Cuschieri K, Rebolj M, et al
    HPValidate-human papillomavirus testing with DNA and mRNA assays on self-collected samples in cervical screening: comparison of test characteristics on three self-sampling devices.
    Br J Cancer. 2025;133:665-673.
    PubMed         Abstract available


    Brachytherapy

  13. KUETE LT, Glennon A, Ptashnik S, Schickel M, et al
    Interstitial cervical needle-guide ring-cap prototype for patient-specific ring-and-tandem brachytherapy.
    Brachytherapy. 2025;24:703-710.
    PubMed         Abstract available

  14. GULSTENE S, Amjad R, Mendez LC
    Understanding the value of paracervical block during gynecologic brachytherapy: A systematic review of the literature.
    Brachytherapy. 2025;24:694-702.
    PubMed         Abstract available


    Braz J Med Biol Res

  15. MARI NL, Souza MVF, Meirelles LEF, Carvalho ARBA, et al
    Chrysin induces cell death and inhibits migration and invasion in squamous cervical carcinoma using a three-dimensional cell culture model.
    Braz J Med Biol Res. 2025;58:e14692.
    PubMed         Abstract available


    Bull World Health Organ

  16. FUADY A, Kasempa C, Lucas E, Nyambe N, et al
    Economic evaluation of thermal ablation compared to cryotherapy and loop diathermy in a screen-and-treat approach to cervical cancer, Zambia.
    Bull World Health Organ. 2025;103:530-540.
    PubMed         Abstract available


    Cad Saude Publica

  17. MIGOWSKI A
    Past, present, and future of screening for cervical cancer in Brazil: lessons learned?
    Cad Saude Publica. 2025;41:e00134625.
    PubMed        


    Cancer Causes Control

  18. OPITO R, Lacika JL, Wabinga H, Orach CG, et al
    Symptom attributions by cervical cancer patients attending specialized care at the Uganda cancer institute: a cross-sectional study.
    Cancer Causes Control. 2025 Sep 2. doi: 10.1007/s10552-025-02062.
    PubMed         Abstract available


    Cancer Control

  19. SADANA A, Omoto J, Sorgi K, Rahangdale L, et al
    Feasibility of Intravaginal Artesunate as an Adjuvant HPV & Cervical Precancer Treatment Among Women Living With HIV in Kenya: Study Protocol for a Phase II Clinical Trial.
    Cancer Control. 2025;32:10732748251374418.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  20. PHILLIPS SA, Denoel S, Wentzensen N, Arbyn M, et al
    Accuracy of HPV Self-Collection Compared with Clinician-Collected HPV Testing and Cytology: A Meta-analysis.
    Cancer Epidemiol Biomarkers Prev. 2025;34:1467-1471.
    PubMed         Abstract available


    Cancer Med

  21. DE SOUSA C, Eksteen C, Engelbrecht AM
    Resveratrol: Sensitising CD44+ Cervical Cancer Cells to Carboplatin and Mitigating Metastasis.
    Cancer Med. 2025;14:e71194.
    PubMed         Abstract available


    Cancer Treat Res Commun

  22. HUANG D, Baldandorj B, Odkhuu E, Amartuvshin E, et al
    ERO1alpha regulates curcumin-induced autophagy via PI3K/AKT pathway.
    Cancer Treat Res Commun. 2025;44:100957.
    PubMed         Abstract available


    Clin Oncol (R Coll Radiol)

  23. DANKULCHAI P, Prasartseree T, Sittiwong W, Thephamongkhol K, et al
    Early Results of Hypofractionated Chemoradiation in Cervical Cancer with 44 Gy/ 20 F vs 45 Gy/ 25 F: A Phase II, Open-Label, Randomised Controlled Trial (HYPOCx-iRex Trial).
    Clin Oncol (R Coll Radiol). 2025;46:103907.
    PubMed         Abstract available

  24. GAN G
    Response to Letter Regarding 'Feasibility Study of an Efficient Plan Pool Adaptive Radiotherapy Technology Based on Low-Dose Computed Tomography for Cervical Cancer'.
    Clin Oncol (R Coll Radiol). 2025;46:103922.
    PubMed        


    Comput Biol Med

  25. SAINI S, Liu X
    Dendrite cross attention for high-dose-rate brachytherapy distribution planning.
    Comput Biol Med. 2025;196.
    PubMed         Abstract available


    Cureus

  26. ASWANI A, Butt E, Akinooye O, Chokapirat C, et al
    Navigating Cervical Cancer Risk in a Patient With Classic Congenital Adrenal Hyperplasia (CAH): A Case Report.
    Cureus. 2025;17:e89331.
    PubMed         Abstract available

  27. KULAL S, H K J, Shivapura Anandakumar A, H R R, et al
    The Sociocultural Determinants of Cervical Cancer Outcomes in India: A Critical Review of Diagnostic Delays and Treatment Disparities.
    Cureus. 2025;17:e88967.
    PubMed         Abstract available

  28. FERNANDES S, Mashharawi N, Bhutta AE, Varghese RM, et al
    Comparison of Self-Collected Versus Clinician-Collected Human Papillomavirus (HPV) Sampling for Cervical Cancer Screening: A Pilot Study in the United Arab Emirates.
    Cureus. 2025;17:e89250.
    PubMed         Abstract available


    Discov Oncol

  29. XI M, Wang X, Xu X, Zhang J, et al
    Predictive value of MHC-related genes in cervical cancer: implications for immunotherapy and prognostic nomogram development.
    Discov Oncol. 2025;16:1662.
    PubMed         Abstract available


    Epidemiol Health

  30. BAE S, Kang YJ, Ahn J, Jang BH, et al
    Socioeconomic factors affecting breast and cervical cancer screening compliance in Asian National Cancer Centers Alliance countries: a systematic review.
    Epidemiol Health. 2025 Aug 28:e2025050. doi: 10.4178/epih.e2025050.
    PubMed         Abstract available


    Folia Med Cracov

  31. BALAJEWICZ-NOWAK M, Kabzinska-Turek M, Kosiawa V
    Association between cervical intraepithelial neoplasia progression and cervicovaginal microbiota status - narrative review.
    Folia Med Cracov. 2024;64:15-21.
    PubMed         Abstract available


    Front Immunol

  32. LI L, Bo Y, Xue D, Qin L, et al
    Ferroptosis-immune crosstalk in cervical cancer: mechanisms and therapeutic implications.
    Front Immunol. 2025;16:1657905.
    PubMed         Abstract available


    Front Oncol

  33. NIU S, Zhang L, Wang L, Zhang X, et al
    Hybrid feature fusion in cervical cancer cytology: a novel dual-module approach framework for lesion detection and classification using radiomics, deep learning, and reproducibility.
    Front Oncol. 2025;15:1595980.
    PubMed         Abstract available


    Ginekol Pol

  34. BIBER W, Fras M, Ciechacka M, Al-Jeabory M, et al
    Adaptation to cancer among Polish patients with cervical cancer in relation to illness acceptance, life satisfaction, and dispositional optimism.
    Ginekol Pol. 2025 Sep 5. doi: 10.5603/gpl.108039.
    PubMed         Abstract available


    Indian J Public Health

  35. DAS S, Sahay MR, Singh AK, Roy P, et al
    Integrating Cervical Cancer Screening and Human Immunodeficiency Virus Care among Women Living with Human Immunodeficiency Virus: A Call for Action.
    Indian J Public Health. 2025;69.
    PubMed         Abstract available


    Int J Biol Macromol

  36. LI N, Zhou S, Zhang Y, Li R, et al
    Immunochromatographic assay for rapid detection of SIGLEC15 to evaluate its therapeutic potential in cervical cancer.
    Int J Biol Macromol. 2025;324.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  37. YANAIHARA N, Tse KY, Lee SJ, Yoo JG, et al
    Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:166-188.
    PubMed         Abstract available

  38. MCCLUGGAGE WG
    New histopathological and molecular findings in gynecological cancers.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70283.
    PubMed         Abstract available

  39. BHATLA N, Aoki D, Sharma DN, Sankaranarayanan R, et al
    Cancer of the cervix uteri: 2025 update.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:87-108.
    PubMed         Abstract available

  40. RUZINDANA K, Anorlu RI
    Global disparities in gynecologic cancer outcomes: A call for action.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:210-220.
    PubMed         Abstract available

  41. PAIBOONBORIRAK C, Abu-Rustum NR, Wilailak S
    Artificial intelligence in the diagnosis and management of gynecologic cancer.
    Int J Gynaecol Obstet. 2025 Apr 25. doi: 10.1002/ijgo.70094.
    PubMed         Abstract available

  42. WILAILAK S, Kengsakul M, Kehoe S
    Strategic approaches for global cervical cancer elimination: An update review and call for national action.
    Int J Gynaecol Obstet. 2025;171 Suppl 1:120-128.
    PubMed         Abstract available


    Int J Gynecol Cancer

  43. GAO X, Kong Y, Ning Y, Cui Z, et al
    Clinical characteristics and prognosis of rhabdomyosarcoma in the female reproductive system: a population-based analysis using SEER data.
    Int J Gynecol Cancer. 2025;35:101989.
    PubMed         Abstract available

  44. BAEK JY, Park W, Cho WK, Kim HS, et al
    Surgery plus post-operative radiotherapy versus definitive chemoradiotherapy in locally advanced endocervical adenocarcinoma.
    Int J Gynecol Cancer. 2025;35:102013.
    PubMed         Abstract available

  45. KOBAYASHI M, Nakagawa S, Masuda T, Kakuda M, et al
    Clinical and pathological characteristics and outcomes of small cell neuroendocrine carcinoma of the uterine cervix.
    Int J Gynecol Cancer. 2025;35:102011.
    PubMed         Abstract available


    Int J Public Health

  46. OGUNSOLA O, Gaydos LM, Ajayi O, Dieci M, et al
    The CHESS Protocol: A Mixed-Methods Evaluation of an HPV Screening Intervention for Women Living With HIV in Nigeria.
    Int J Public Health. 2025;70:1608716.
    PubMed         Abstract available


    Integr Cancer Ther

  47. VAN WIETMARSCHEN HA, Area-Gomez E, Picard M, Goodheart MJ, et al
    Metabolic Effects of Healing Touch During Cervical Cancer Treatment: An Exploratory Analysis.
    Integr Cancer Ther. 2025;24:15347354251367793.
    PubMed         Abstract available


    Iran J Basic Med Sci

  48. ALIKHANZADEH M, Imanparast A, Einafshar E, Gholamhosseinian H, et al
    Evaluation of Cherenkov-induced photodynamic therapy of biohybrid photosensitive graphene oxide nanoplatform in cervical cancer cells.
    Iran J Basic Med Sci. 2025;28:1392-1405.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  49. QUAYSON H, Bonney JHK, Sam D, Nuer-Allornuvor GF, et al
    Expression patterns of plasma microRNAs in patients with cervical cancer from two teaching hospitals in Ghana.
    J Cancer Res Clin Oncol. 2025;151:242.
    PubMed         Abstract available


    J Cancer Res Ther

  50. ZHOU L, Bai Y, Diao P, Zeng S, et al
    Comparison of postoperative adjuvant therapy for early-stage cervical cancer: A surveillance, epidemiology, and end results analysis.
    J Cancer Res Ther. 2025;21:834-841.
    PubMed         Abstract available


    J Gynecol Oncol

  51. WANG Y, Lu Q, Na J, Wang X, et al
    Safety and efficacy of radical hysterectomy based on embryo development-originated in the treatment of early cervical cancer: a single-arm meta-analysis.
    J Gynecol Oncol. 2025 Aug 25. doi: 10.3802/jgo.2026.
    PubMed         Abstract available


    J Infect Public Health

  52. UYAR NY, Bodur H, Erdem MO, Altinisik IAK, et al
    Concentrated urine as an alternative to cervical smear samples enabling easy screening of HPV in large populations.
    J Infect Public Health. 2025;18:102857.
    PubMed         Abstract available


    J Med Life

  53. SAVELIEV GM, Varlas VN, Piron-Dumitrascu M, Suciu N, et al
    Cervical cancer screening in Europe and Romania: a review of policies, progress, and persistent disparities.
    J Med Life. 2025;18:604-607.
    PubMed         Abstract available


    J Multidiscip Healthc

  54. TOFFAHA K, Simsekler MCE, Sleptchenko A, Kortt MA, et al
    A Machine Learning and Bayesian Belief Network Approach to Predicting Cervical Cancer Risk: Implications for Risk Management.
    J Multidiscip Healthc. 2025;18:5199-5211.
    PubMed         Abstract available


    J Proteome Res

  55. NI M, Wan D, Li M, Wu J, et al
    Deficiency of the UBE2C/F264 Axis Underlies Intrinsic Radioresistance in Cervical Carcinoma.
    J Proteome Res. 2025;24:4665-4673.
    PubMed         Abstract available


    JNCI Cancer Spectr

  56. KRIEGER N, Moallef S, Cowger TL, Chen JT, et al
    Political determinants of US states' screening-amenable cancer stage at diagnosis and premature cancer mortality.
    JNCI Cancer Spectr. 2025;9:pkaf073.
    PubMed         Abstract available


    Kaohsiung J Med Sci

  57. WANG Y, Li C
    MYB Activates the Hedgehog Signaling Pathway to Repress Natural Killer Cytotoxicity in Cervical Cancer.
    Kaohsiung J Med Sci. 2025 Sep 1:e70084. doi: 10.1002/kjm2.70084.
    PubMed         Abstract available


    MethodsX

  58. R A, Prasad S
    A blockchain-enabled healthcare system for cervical cancer risk prediction using enhanced metaheuristic optimised graph convolutional attention based GRU.
    MethodsX. 2025;15:103564.
    PubMed         Abstract available


    Pathol Res Pract

  59. LAOHAWETWANIT T, Apornvirat S, Asaturova A, Li H, et al
    Evaluation of general-purpose large language models as diagnostic support tools in cervical cytology.
    Pathol Res Pract. 2025;274:156159.
    PubMed         Abstract available


    PLoS One

  60. BULAMBA RM, Kyasanku E, Nalugoda F, Daama A, et al
    Assessing Knowledge, Uptake and Factors associated with cervical cancer screening among women in selected communities of Wakiso district in Uganda: A population-based study.
    PLoS One. 2025;20:e0317641.
    PubMed         Abstract available

  61. DEN'O ZD, Paulos W, Markos D, Oche WO, et al
    Human papilloma virus vaccination uptake and associated factors among adolescent girls in Merab Abaya district, Gamo zone, Southern Ethiopia: Mixed methods.
    PLoS One. 2025;20:e0330760.
    PubMed         Abstract available


    Radiother Oncol

  62. SERBAN M, Spampinato S, de Leeuw A, Fortin I, et al
    Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis.
    Radiother Oncol. 2025;210:110954.
    PubMed         Abstract available


    Reprod Sci

  63. ZOU D, Wu X, Xin X, Xu T, et al
    Construction and Validation of a Novel Prognostic Model Based on Cervical Cancer-Related Genes.
    Reprod Sci. 2025 Sep 4. doi: 10.1007/s43032-025-01973.
    PubMed         Abstract available


    Rev Panam Salud Publica

  64. BARCENA BARBEIRA P, Paolino M, Binder F, Almonte M, et al
    Implementation of second round of HPV-based screening for cervical cancer in programmatic contexts in Argentina.
    Rev Panam Salud Publica. 2025;49:e92.
    PubMed         Abstract available


    Rev Peru Med Exp Salud Publica

  65. ROSAS-MENDOZA MA, Santos-Rosales YR, Chilipio-Chiclla MA
    Frequency and factors associated with the preference for self-testing for human papillomavirus detection.
    Rev Peru Med Exp Salud Publica. 2025;42:166-174.
    PubMed         Abstract available


    Saudi Med J

  66. BANJER HJ, Tayeb HH, Alzahrani KJ, Alsufiani SM, et al
    Cervical cancer risk and high-risk HPV types distribution in Saudi Arabia: Trends from a national laboratory-based study.
    Saudi Med J. 2025;46:992-999.
    PubMed         Abstract available


    Sci Rep

  67. ZHANG T, Ji T, Duan Z, Xue Y, et al
    Retraction Note: Long non-coding RNA MLLT4 antisense RNA 1 induces autophagy to inhibit tumorigenesis of cervical cancer through modulating the myosin-9/ATG14 axis.
    Sci Rep. 2025;15:32078.
    PubMed        

  68. MASAMBA MAKANANI C, Nyondo-Mipando AL, Jumbe V
    Barriers and strategies to enhance HPV vaccine uptake in adolescents living with HIV and their guardians in Lilongwe, Malawi.
    Sci Rep. 2025;15:32230.
    PubMed         Abstract available

  69. LIU Y, Li R, Du H, Wu R, et al
    HPV negative conversion following Hiporfin PDT for HPV associated HSIL in the female lower reproductive tract.
    Sci Rep. 2025;15:31973.
    PubMed         Abstract available


    Support Care Cancer

  70. NOGUEIRA CM, Reis BS, Meneses AFP, Mellado BH, et al
    Unveiling delays: understanding the diagnostic pathways of women with advanced cervical cancer.
    Support Care Cancer. 2025;33:826.
    PubMed         Abstract available


    Toxicol Appl Pharmacol

  71. YANG G, Mo Y, Rong H, Guo B, et al
    Caulerpin suppresses tumor-associated angiogenesis and tumor growth via Hippo signaling in cervical cancer.
    Toxicol Appl Pharmacol. 2025;504:117541.
    PubMed         Abstract available


    Transl Oncol

  72. JIA Y, Zhang F, Zou K, Zou L, et al
    A clinical study on the efficacy of concurrent chemoradiotherapy combined with targeted therapy and hyperthermia in patients with locally advanced cervical cancer.
    Transl Oncol. 2025;61:102516.
    PubMed         Abstract available


    Turk J Obstet Gynecol

  73. GULER CEKIC S, Bulut M, Aldikactioglu Talmac M, Aydin E, et al
    Risk factors for parametrial invasion in early-stage cervical cancer: Toward less radical surgery.
    Turk J Obstet Gynecol. 2025;22:237-245.
    PubMed         Abstract available

  74. YANAZUME S, Kitazono I, Togami S, Tanimoto A, et al
    Potential biomarkers for predicting the efficacy of a pembrolizumab-containing regimen in advanced cervical cancer: A real-world analysis.
    Turk J Obstet Gynecol. 2025;22:246-256.
    PubMed         Abstract available


    Women Health

  75. PURDY NL, Katz ML, Reiter PL
    Women's acceptability of HPV self-collection in a healthcare setting following FDA approval in the United States.
    Women Health. 2025;65:606-617.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.